Case report suggests second primary glioblastoma in ALK-positive lung adenocarcinoma patient treated with ensartinib and lorlatinib
A single patient case warns doctors to check for second cancers when tumors act strangely
This case report describes a 63-year-old female with ALK-positive lung adenocarcinoma who received ensartinib, lorlatinib, and stereotactic …
A 63-year-old woman with lung cancer developed a new brain tumor that was not a metastasis. Doctors must carefully examine unusual tumor gro…
Systematic review and meta-analysis shows individualized EIT-guided PEEP reduces postoperative atelectasis in laparoscopic surgery patients
Individualized EIT-guided PEEP reduces lung collapse after laparoscopic surgery
This systematic review and meta-analysis evaluated individualized EIT-guided PEEP versus fixed PEEP in 290 patients undergoing laparoscopic …
A meta-analysis shows individualized lung pressure settings guided by EIT reduce lung collapse and improve oxygenation after laparoscopic su…
FDA Approves Adempas (riociguat) for Chronic Thromboembolic and Pulmonary Arterial Hypertension
FDA approves new pill Adempas for two types of high blood pressure in lungs
The FDA approved Adempas (riociguat) for adults with persistent/recurrent CTEPH after surgery or inoperable CTEPH, and for PAH (WHO Group 1)…
The FDA approved Adempas (riociguat) for two forms of pulmonary hypertension: chronic thromboembolic pulmonary hypertension (CTEPH) and pulm…
Post hoc reanalysis suggests stereotactic radiotherapy may improve local control in medically inoperable Stage I non-small cell lung cancer
New analysis gives hope for early lung cancer patients who cannot have surgery
This post hoc Bayesian reanalysis of the LUSTRE trial evaluated stereotactic radiotherapy versus conventional radiotherapy in medically inop…
A new statistical review suggests a focused radiation approach may better control early lung cancer for patients who cannot undergo surgery.
Meta-analysis finds immunotherapy improves survival in mesothelioma
Immunotherapy boosts survival time for mesothelioma patients across all treatment lines
This meta-analysis of 2549 patients with mesothelioma found that immunotherapy significantly improved overall survival (HR 0.78, p=0.0005). …
New research shows immunotherapy helps mesothelioma patients live longer, offering hope where few options existed before.
Systematic review and meta-analysis of repeat corticosteroids in PPROM shows increased maternal infection risk
Repeat steroid shots for PPROM may raise infection risk without helping babies
This systematic review and meta-analysis evaluated repeat courses of corticosteroids versus a single course in women with preterm premature …
A new review suggests giving two rounds of steroids to women with PPROM could hurt the mother without helping the baby
Real-world meta-analysis supports pembrolizumab for advanced NSCLC with high PD-L1
Real-world data confirms pembrolizumab offers long-term survival for advanced lung cancer patients
A systematic review and meta-analysis of real-world studies evaluated first-line pembrolizumab monotherapy for advanced NSCLC with high PD-L…
New data from thousands of patients shows pembrolizumab provides reliable long-term survival for advanced lung cancer without major safety s…
Meta-analysis shows biologic therapies reduce annual exacerbations in COPD patients with high eosinophils while maintaining safety profiles
New drugs cut COPD flare-ups for patients with high eosinophils
This living evidence synthesis evaluates dupilumab and mepolizumab in 7,359 COPD patients. Results indicate reduced annual exacerbation rate…
New biologic drugs lower the yearly number of COPD flare-ups for patients with high eosinophil counts while keeping side effects low
Meta-analysis finds balance training improves balance in COPD patients receiving pulmonary rehabilitation
Adding Balance Training to COPD Rehab Changes Lives
This meta-analysis of seven randomized trials in COPD patients aged 50 years or older found that adding balance training to pulmonary rehabi…
A simple addition to standard lung rehab, balance training, helps COPD patients stand steadier, feel more confident, and live better, a new …
FDA Approves Breztri Aerosphere (budesonide/glycopyrrolate/formoterol) for COPD Maintenance
FDA approves new triple-combination inhaler Breztri Aerosphere for COPD.
The FDA approved Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) for maintenance treatment of COPD. It is a triple-combin…
The FDA approved Breztri Aerosphere, a triple-combination inhaler, for the long-term treatment of chronic obstructive pulmonary disease (COP…
Lung Ultrasound Shows Good Diagnostic Accuracy for ARDS in Meta-Analysis of 5888 Patients
Lung ultrasound shows high accuracy for detecting severe breathing trouble in ICU patients
This systematic review and meta-analysis of 5888 patients found that lung ultrasound (LUS) has good diagnostic accuracy for acute respirator…
A large review of 5,888 patients found lung ultrasound is a highly accurate, safe way to check for severe lung injury without using radiatio…
Pembrolizumab improves overall survival versus chemotherapy in Chinese patients with advanced NSCLC and PD-L1 expression
Five-year follow-up shows pembrolizumab extends life for Chinese lung cancer patients with high PD-L1
This Phase 3 trial evaluated pembrolizumab monotherapy against chemotherapy in Chinese patients with previously untreated locally advanced o…
A five-year look at a Chinese lung cancer trial shows pembrolizumab improved survival compared to chemotherapy for patients with high PD-L1 …